去甲腎上腺素再攝取抑製劑（norepinephrine reuptake inhibitor，NRI，NERI）又稱正腎上腺素再攝取抑製劑，為一種抑制去甲腎上腺素再攝取的藥物。該藥通過阻斷或減緩去甲腎上腺素的再攝取而發揮作用[1]。而去甲腎上腺素為腦中調節注意力、搏動性和活動水平的重要物質，該藥對治療注意力缺陷多動症（ADHD）有明顯的作用。
現有的去甲腎上腺素再攝取抑製劑
- 阿托莫西汀
- Amedalin (UK-3540-1)
- CP-39,332
- Daledalin (UK-3557-15)
- Edivoxetine (LY-2216684)
- Esreboxetine
- Lortalamine (LM-1404)
- 馬吲哚 (Mazanor, Sanorex)
- Nisoxetine (LY-94,939)
- 瑞波西汀 (Edronax, Vestra)
- Talopram (Lu 3-010)
- Talsupram (Lu 5-005)
- Tandamine (AY-23,946)
- Viloxazine (Vivalan)
- 安非他酮 (Wellbutrin, Zyban)
- Ciclazindol (Wy-23,409)
- Manifaxine (GW-320,659)
- Radafaxine (GW-353,162)
- Tapentadol (Nucynta)
- Teniloxazine (Lucelan, Metatone)
參考
Wikiwand in your browser!
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.
Remove ads